Cargando…
Cardiac soluble guanylate cyclase protects against the cardiac dysfunction induced by chronic doxorubicin treatment in mice
Autores principales: | Vandenwijngaert, Sara, Swinnen, Melissa, Gillijns, Hilde, Caluwé, Ellen, Tainsh, Robert E, Nathan, Daniel I, Allen, Kaitlin, Bartunek, Jozef, Brouckaert, Peter, Scherrer-Crosbie, Marielle, Bloch, Kenneth D, Janssens, Stefan P, Buys, Emmanuel S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565628/ http://dx.doi.org/10.1186/2050-6511-16-S1-A96 |
Ejemplares similares
-
Gender-Specific Modulation of the Response to Arterial Injury by Soluble Guanylate Cyclase α1
por: Vermeersch, Pieter, et al.
Publicado: (2009) -
Androgen-sensitive hypertension associated with soluble guanylate cyclase alpha1 deficiency is mediated by 20-HETE
por: Vandenwijngaert, Sara, et al.
Publicado: (2015) -
Genetic mapping of a modifier locus affecting hypertension in soluble guanylate cyclase α(1) deficient mice
por: Buys, Emmanuel S, et al.
Publicado: (2011) -
Soluble Guanylate Cyclase α(1)–Deficient Mice: A Novel Murine Model for Primary Open Angle Glaucoma
por: Buys, Emmanuel S., et al.
Publicado: (2013) -
Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice
por: Thoonen, Robrecht, et al.
Publicado: (2015)